StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$63.65−0.23 (-0.36%)

Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –

Eton Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Eton Pharmaceuticals's price to book ratio was 41.5× on Nov 11, 2026, against 18.7× a year earlier. Over the last 5 years it ranged from 4.0× to 41.5×, with a median of 7.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202641.5×+21.9
2025Dec 31, 202519.6×−1.9
2024Dec 31, 202421.5×+14.9
2023Dec 29, 20236.7×+0.3
2022Dec 30, 20226.4×−0.4
2021Dec 31, 20216.7×−116.2
2020Dec 31, 2020122.9×+112.6
2019Dec 31, 201910.4×–

More Eton Pharmaceuticals figures

See a number that looks wrong?